Free Trial

Bloom Burton's Rating of Conavi Medical on 7/6/2025

On July 6, 2025, Bloom Burton updated its outlook on Conavi Medical (CVE:CNVI) with the action "Upgrade", setting a "Strong-Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Bloom Burton

DateCompanyAction
6/5/2025
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
Downgrade
1/10/2025
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
Downgrade
5/2/2024
Cybin Inc. stock logo
CYBN
Cybin
Reiterated Rating
4/19/2024
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
Upgrade
3/20/2024
Fusion Pharmaceuticals Inc. stock logo
FUSN
Fusion Pharmaceuticals
Downgrade
2/13/2024
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
Downgrade
More Ratings From Bloom Burton